EP 1909793 A2 20080416 - USE OF PHOSPHODIESTERASE TYPE 5 INHIBITORS FOR THE PREVENTION AND TREATMENT OF DISEASES OR HEALTH DISORDERS AND DISPENSING SYSTEM FOR SAID INHIBITORS
Title (en)
USE OF PHOSPHODIESTERASE TYPE 5 INHIBITORS FOR THE PREVENTION AND TREATMENT OF DISEASES OR HEALTH DISORDERS AND DISPENSING SYSTEM FOR SAID INHIBITORS
Title (de)
VERWENDUNG VON PHOSPHODIESTERASE TYP 5-HEMMERN FÜR DIE PRÄVENTION UND BEHANDLUNG VON ERKRANKUNGEN ODER GESUNDHEITSSTÖRUNGEN, SOWIE ABGABESYSTEME FÜR DIESELBEN
Title (fr)
UTILISATION D'INHIBITEURS DE PHOSPHODIESTERASE TYPE 5 POUR LA PREVENTION ET LE TRAITEMENT DE MALADIES OU DE TROUBLES, ET SYSTEMES D'ADMINISTRATION ASSOCIES
Publication
Application
Priority
- IB 2006001013 W 20060425
- DE 102005033725 A 20050715
Abstract (en)
[origin: WO2007010337A2] The invention relates to the use of phosphodiesterase (PDE) type 5 inhibitors or their pharmaceutically compatible salts for producing a medicament for preventing and/or treating diseases or health disorders, which are associated with an excessive proliferation of adipose tissue in the body. In particular, the invention relates to the use of phosphodiesterase type 5 inhibitors for preventing and treating adiposity. In addition, the invention relates to special dispensing systems for the vaginal and sub-cutaneous administration of PDE5 inhibitors.
IPC 8 full level
A61K 31/4985 (2006.01); A61F 6/08 (2006.01); A61K 9/00 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); A61P 9/04 (2006.01)
CPC (source: EP)
A61K 9/0036 (2013.01); A61K 31/4985 (2013.01); A61P 3/04 (2017.12); A61P 3/10 (2017.12); A61P 9/04 (2017.12)
Citation (search report)
See references of WO 2007010337A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2007010337 A2 20070125; WO 2007010337 A3 20070329; WO 2007010337 A8 20070503; EP 1909793 A2 20080416
DOCDB simple family (application)
IB 2006001013 W 20060425; EP 06744566 A 20060425